Display options
Cite
Jones-Lecointe A, Green PJ, Lee HA. Sub-optimal doses of human recombinant erythropoietin markedly lower serum ferritin. Clin Lab Haematol. 1991;13(3):251-3doi: 10.1111/j.1365-2257.1991.tb00280.x.
Jones-Lecointe, A., Green, P. J., & Lee, H. A. (1991). Sub-optimal doses of human recombinant erythropoietin markedly lower serum ferritin. Clinical and laboratory haematology, 13(3), 251-3. https://doi.org/10.1111/j.1365-2257.1991.tb00280.x
Jones-Lecointe, A, et al. "Sub-optimal doses of human recombinant erythropoietin markedly lower serum ferritin." Clinical and laboratory haematology vol. 13,3 (1991): 251-3. doi: https://doi.org/10.1111/j.1365-2257.1991.tb00280.x
Jones-Lecointe A, Green PJ, Lee HA. Sub-optimal doses of human recombinant erythropoietin markedly lower serum ferritin. Clin Lab Haematol. 1991;13(3):251-3. doi: 10.1111/j.1365-2257.1991.tb00280.x. PMID: 1794227.
Copy Download .nbib Format: NLM
Share it on
Full text links
Wiley

Clin Lab Haematol. 1991;13(3):251-3. doi: 10.1111/j.1365-2257.1991.tb00280.x.

Sub-optimal doses of human recombinant erythropoietin markedly lower serum ferritin.

Clinical and laboratory haematology

A Jones-Lecointe, P J Green, H A Lee

Affiliations

  1. Haematology Department, St. Mary's Hospital, Portsmouth, Hants, UK.

PMID: 1794227 DOI: 10.1111/j.1365-2257.1991.tb00280.x

Abstract

Human recombinant erythropoietin in full dose substantially raises the haemoglobin in patients with end stage renal disease on dialysis. In lower doses no or little rise in haemoglobin is achieved but the ferritin, often very high before treatment, is disproportionately lowered. The hormone therefore may be useful in reducing iron overload in other situations.

Substances

MeSH terms

Publication Types

LinkOut - more resources